Wealthedge Investment Advisors »

Adicet Bio shares owned by Wealthedge Investment Advisors

Quarter-by-quarter ownership of Adicet Bio (ACET) shares owned by Wealthedge Investment Advisors from 13F filings

Historical chart of Wealthedge Investment Advisors investment in Adicet Bio

Tip: Access up to 7 years of quarterly data

All positions including Adicet Bio held by Wealthedge Investment Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Adicet Bio by Wealthedge Investment Advisors

Quarter filed Position value Share count Share price at filing
2025-09-30 $243k 300k 0.81
2025-06-30 $191k 313k 0.61
2025-03-31 $172k 228k 0.76
2024-12-31 $71k 74k 0.96

More positions owned by Wealthedge Investment Advisors

Spdr S&p 500 Etf Tr Tr Unit (SPY)
Pimco Etf Tr 15+ Yr Us Tips (LTPZ)
Microsoft Corporation (MSFT)
Agf Invts Tr Us Market Netrl (BTAL)
Ishares Tr Core S&p500 Etf (IVV)
NVIDIA Corporation (NVDA)
Vanguard Index Fds Mid Cap Etf (VO)
Apple (AAPL)
Schwab Strategic Tr Us Tips Etf (SCHP)
Janus Detroit Str Tr Hendrson Aaa Cl (JAAA)
Vanguard Index Fds Value Etf (VTV)
Schwab Strategic Tr Us Lcap Gr Etf (SCHG)
Ishares Tr 0-3 Mnth Treasry (SGOV)
Ishares Tr Russell 2000 Etf (IWM)
Bristol Myers Squibb (BMY)

View all positions for Wealthedge Investment Advisors

Top funds holding Adicet Bio

OrbiMed Advisors
Tang Capital Management
RA Capital Management
Goldman Sachs Group
Vanguard Group
Carlyle
Acadian Asset Management
Renaissance Technologies
Regeneron Pharmaceuticals
Bridgeway Capital Management
Two Sigma Investments
Two Sigma Advisers
Geode Capital Management
Alyeska Investment Group
Rbf Capital

View all funds holding Adicet Bio